MRI — The Imaging Machine That Detects Cancer Without Radiation
Raymond Damadian's 1974 patent describes using nuclear magnetic resonance to distinguish cancerous tissue from healthy tissue — the foundational discovery that launched MRI scanning, though Damadian controversially did not share the Nobel Prize.
Patent Number
US 3789832
Status
Active
Filing Date
March 17, 1972
Grant Date
February 5, 1974
Expiration
~March 1992 (estimated)
Claims
21
Assignee
Individual
Inventors
R Damadian
Citations
83 forward · 3 backward
What it covers
This patent describes a method of using nuclear magnetic resonance (NMR) to detect differences between cancerous and healthy tissue. NMR works by placing tissue in a strong magnetic field and then applying radio frequency pulses. The hydrogen nuclei (protons) in water and fat molecules absorb the radio energy and emit their own signals as they relax back to their baseline state. The key discovery: cancerous tissues have higher water content and different molecular environments than healthy tissues, causing their protons to relax differently — with longer T1 and T2 relaxation times. By measuring these relaxation times, a scanner can distinguish tumor from normal tissue without surgery, biopsy, or ionizing radiation.
What it doesn't cover
- —The image reconstruction algorithms (Fourier transform methods) that turn NMR signals into 2D or 3D images — developed separately by Lauterbur and Mansfield
- —Gradient coils that spatially encode the NMR signal — Lauterbur's key innovation enabling spatial imaging
- —Functional MRI (fMRI) — measuring blood oxygenation to detect brain activity
- —MRI contrast agents (gadolinium) — injected materials that enhance image contrast
The clever bit
Damadian was a medical doctor and physicist who in 1971 placed a live rat inside an NMR machine and showed that cancer cells produced different NMR signals than normal cells — specifically, that tumor tissue had longer T1 relaxation times. This was the first evidence that NMR could distinguish tissue types, suggesting a non-invasive cancer detection tool. He published the finding in Science in 1971. The subsequent controversy: Paul Lauterbur independently developed the mathematics of spatial NMR imaging (MRI as we know it — the actual image-forming system) and Peter Mansfield improved the speed and quality of acquisition. In 2003, the Nobel Prize in Physiology or Medicine went to Lauterbur and Mansfield — not Damadian, despite his foundational tissue-discrimination discovery. Damadian protested publicly, taking out full-page ads in major newspapers.
Why it matters
MRI is the most significant medical imaging advance since X-rays. Unlike CT scans, it uses no ionizing radiation; unlike ultrasound, it produces high-resolution cross-sectional images of any body part. The ability to distinguish tissue types non-invasively revolutionized oncology, neurology, cardiology, and orthopedics. Damadian's foundational patent on tissue discrimination using NMR generated substantial licensing revenue for his company FONAR — GE, Siemens, and other scanner manufacturers paid royalties. The controversy over the Nobel Prize omission remains one of the most discussed in science: did the prize committee deliberately exclude Damadian, or did his tissue-discrimination work not qualify as the key invention of spatial imaging?
Real-world examples
- 1.Damadian built the first whole-body MRI scanner ('Indomitable') in 1977 at his company FONAR — it took 5 hours to produce the first human image
- 2.Modern MRI machines operate at 1.5 to 7 Tesla field strength (vs. Damadian's early 0.1 Tesla), producing millimeter-resolution images in seconds
- 3.Over 40 million MRI scans are performed annually in the U.S. — it is the primary diagnostic tool for soft tissue injury, neurological disease, and cancer staging
Glossary
Generated by PatentBrief · Not legal advice · patentbrief.org
US 3789832 · 2026